UCSF Offers "Heart to Heart" Seminars for Public

February 02, 2005
News Office: Vanessa deGier (415) 502-6397

UCSF's Heart and Vascular Center -- dedicated to raising awareness of heart disease -- is offering public lectures on a range of heart-related health subjects throughout February, which is National Heart Month.

"Heart to Heart Seminars" feature UCSF cardiologists and surgeons speaking on a variety of topics, including prevention of heart disease, congenital heart problems, cardiovascular disease, and treatment options.

Presentations will be noon to 1 p.m. on the UCSF Campus on Parnassus Avenue. All events are free and open to everyone.

* FRIDAY, FEBRUARY 4 - "WOMEN AND HEART DISEASE" -- Dr. Rita Redberg, director, Women's Cardiovascular Services. Cole Hall, Medical Sciences Building, 513 Parnassus Avenue.

* FRIDAY, FEBRUARY 11 - "CONGESTIVE HEART FAILURE" -- Dr. Ann Thorson, cardiologist. Room 300, Health Sciences West, enter at 513 Parnassus Avenue.

* MONDAY FEBRUARY 14 - "CONGENITAL HEART DISEASE" -- Dr. Elyse Foster, director, Adult Echocardiography Laboratory and the Adult Congenital Heart Disease Service. Room N225, School of Nursing Building, enter at 513 Parnassus Avenue.

* FRIDAY, FEBRUARY 18 - "PREVENTION OF CARDIOVASCULAR DISEASES" -- Dr. Michael Crawford, chief of Clinical Cardiology. Cole Hall, Medical Sciences Building, 513 Parnassus Avenue.

* FRIDAY, FEBRUARY 25 - "ADVANCES IN MINIMALLY INVASIVE TREATMENT OF PERIPHERAL VASCULAR DISEASE" -- Dr. Darren Schneider, vascular surgeon and interventional radiologist. Cole Hall, Medical Sciences Building, 513 Parnassus Avenue.

* MONDAY, FEBRUARY 28 - "HEART FAILURE AND DEVICES" -- Dr. Donald Hill, cardiac surgeon. Room N225, School of Nursing Building, enter at 513 Parnassus.

The UCSF Heart and Vascular Center brings together cardiologists, cardiac surgeons, vascular surgeons, interventional radiologists and other specialists to provide the most advanced and effective treatments, many of them developed at UCSF Medical Center. Services range from prevention and screening programs to providing the newest treatments for the most severe and rare heart and vascular problems.

This news release has been modified for the website